Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The molecular mechanisms of
multiple myeloma
are not well defined.
EEN
is an endocytosis-regulating molecule. Here we report that
EEN
regulates the proliferation and survival of
multiple myeloma
cells, by regulating IGF-1 secretion. In the present study, we observed that
EEN
expression paralleled with cell proliferation,
EEN
accelerated cell proliferation, facilitated cell cycle transition from G1 to S phase by regulating cyclin-dependent kinases (CDKs) pathway, and delayed cell apoptosis via Bcl2/Bax-mitochondrial pathway. Mechanistically, we found that
EEN
was indispensable for insulin-like growth factor-1 (IGF-1) secretion and the activation of protein kinase B-mammalian target of rapamycin (Akt-mTOR) pathway. Exogenous IGF-1 overcame the phenotype of
EEN
depletion, while IGF-1 neutralization overcame that of
EEN
over-expression. Collectively, these data suggest that
EEN
may play a pivotal role in excessive cell proliferation and insufficient cell apoptosis of bone marrow plasma cells in
multiple myeloma
. Therefore,
EEN
may represent a potential diagnostic marker or therapeutic target for
multiple myeloma
.
...
PMID:EEN regulates the proliferation and survival of multiple myeloma cells by potentiating IGF-1 secretion. 2470 50